title: Letter to the Editor Regarding the Article "Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma".
authors.affiliation: 1 Department of Nuclear Medicine, University Clinic , Würzburg, Germany .
authors.forename: Peter
authors.initials: P
authors.lastname: Schneider
authors.affiliation: 2 Clinic of Nuclear Medicine, University Clinic , Würzburg, Germany .
authors.forename: Rita
authors.initials: R
authors.lastname: Schneider
authors.affiliation: 3 University Clinic , Children's Hospital, Mainz, Germany .
authors.forename: Mara
authors.initials: M
authors.lastname: Schneider
authors.affiliation: 4 Medical Director, University Clinic , Würzburg, Germany .
authors.forename: Christoph
authors.initials: C
authors.lastname: Reiners
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000097:blood* / Q000150:complications*; D013964:Thyroid Neoplasms / Q000097:blood* / Q000150:complications*; D013972:Thyrotropin / Q000037:antagonists & inhibitors*
chemical_list: D013972:Thyrotropin